New hope for colorectal cancer: targeted drug aims to wipe out hidden cancer cells

NCT ID NCT07023289

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 28 times

Summary

This study tests a new drug, telisotuzumab adizutecan, against standard treatments in about 140 adults with colorectal cancer who have completed initial chemotherapy and show no visible tumors, but still have cancer DNA in their blood. The goal is to see if the new drug can delay or prevent the cancer from coming back. Participants will receive either the new drug or standard care, and their health will be closely monitored.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aarhus Universitetshospital - Skejby /ID# 274498
RECRUITING

Aarhus, Central Jutland, 8200, Denmark
Aichi Cancer Center /ID# 275479
RECRUITING

Nagoya, Aichi-ken, 464-8681, Japan
Asan Medical Center /ID# 274454
RECRUITING

Seoul, Seoul Teugbyeolsi, 05505, South Korea
Azienda Ospedaliera Universitaria Federico II - Naples /ID# 273540
RECRUITING

Naples, Napoli, 80131, Italy
Azienda Ospedaliero Universitaria Careggi /ID# 273604
RECRUITING

Florence, Firenze, 50134, Italy
China Medical University Hospital /ID# 274644
RECRUITING

Taichung, 40447, Taiwan
Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621
RECRUITING

Huntsville, Alabama, 35805, United States
Duke University Medical Center /ID# 279457
RECRUITING

Durham, North Carolina, 27710, United States
Gifu University Hospital /ID# 274179
RECRUITING

Gifu, Gifu, 501-1194, Japan
Hospital Universitario La Paz /ID# 273718
RECRUITING

Madrid, 28046, Spain
Hospital Universitario Virgen del Rocio /ID# 273720
RECRUITING

Seville, Sevilla, 41013, Spain
Hospital Universitario de Salamanca /ID# 273719
RECRUITING

Salamanca, 37007, Spain
IRCCS Istituto Clinico Humanitas /ID# 273566
RECRUITING

Rozzano, Lombardy, 20089, Italy
Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586
RECRUITING

Fairfax, Virginia, 22031, United States
Johns Hopkins Hospital /ID# 275645
RECRUITING

Baltimore, Maryland, 21287, United States
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 273745
RECRUITING

Kaohsiung City, 807, Taiwan
Kyushu University Hospital /ID# 273710
RECRUITING

Fukuoka, Fukuoka, 812-8582, Japan
Massachusetts General Hospital /ID# 273608
RECRUITING

Boston, Massachusetts, 02114, United States
Mayo Clinic Hospital Jacksonville /ID# 274472
RECRUITING

Jacksonville, Florida, 32224, United States
Mayo Clinic-Rochester /ID# 273508
RECRUITING

Rochester, Minnesota, 55905, United States
Moffitt Cancer Center /ID# 274372
RECRUITING

Tampa, Florida, 33612, United States
NHO Revive Research Institute, LLC /ID# 274209
NOT_YET_RECRUITING

Lincoln, Nebraska, 68506, United States
National Cancer Center Hospital East /ID# 273614
RECRUITING

Kashiwa-shi, Chiba, 277-8577, Japan
National Hospital Organization Osaka National Hospital /ID# 274306
RECRUITING

Osaka, Osaka, 540-0006, Japan
National Taiwan University Hospital /ID# 273580
RECRUITING

Taipei, 100, Taiwan
Northwell Health Center for Advanced Medicine. /ID# 275331
RECRUITING

Lake Success, New York, 11042, United States
Northwest Cancer Specialists /ID# 275151
RECRUITING

Portland, Oregon, 97227-1800, United States
Odense University Hospital /ID# 274970
RECRUITING

Odense C, Region Syddanmark, 5000, Denmark
Parkview Physicians Group (Ppg) /ID# 275254
NOT_YET_RECRUITING

Fort Wayne, Indiana, 46845, United States
Providence Medical Foundation - Fullerton /ID# 274207
RECRUITING

Fullerton, California, 92835-3826, United States
SCRI Oncology Partners /ID# 274522
RECRUITING

Nashville, Tennessee, 37203, United States
Samsung Medical Center /ID# 274452
RECRUITING

Seoul, Seoul Teugbyeolsi, 06351, South Korea
Scri Minnesota Oncology Hematology, P.A. /ID# 275149
RECRUITING

Minneapolis, Minnesota, 55404, United States
Seoul National University Hospital /ID# 274451
RECRUITING

Seoul, Seoul Teugbyeolsi, 03080, South Korea
Shizuoka Cancer Center /ID# 275480
RECRUITING

Sunto-gun, Shizuoka, 411-8777, Japan
Texas Oncology - Central/South Texas /ID# 275154
RECRUITING

Austin, Texas, 78705, United States
Texas Oncology-Grapevine /ID# 275155
RECRUITING

Grapevine, Texas, 76051, United States
The Center For Cancer And Blood Disorders /ID# 278512
RECRUITING

Fort Worth, Texas, 76104, United States
The University of Texas MD Anderson Cancer Center /ID# 273539
RECRUITING

Houston, Texas, 77030, United States
Tohoku University Hospital /ID# 275481
RECRUITING

Sendai, Miyagi, 980-8574, Japan
USC Norris Comprehensive Cancer Center /ID# 274550
RECRUITING

Los Angeles, California, 90033, United States
Universitair Ziekenhuis Leuven /ID# 278668
RECRUITING

Leuven, Vlaams-Brabant, 3000, Belgium
University of Chicago Medical Center /ID# 274742
RECRUITING

Chicago, Illinois, 60637, United States
University of Michigan Health System - Ann Arbor /ID# 273511
RECRUITING

Ann Arbor, Michigan, 48109, United States
Vejle Sygehus /ID# 274368
RECRUITING

Vejle, Region Syddanmark, 7100, Denmark
Virginia Cancer Specialists - Fairfax /ID# 274339
RECRUITING

Fairfax, Virginia, 22031, United States
Yokohama City University Medical Center /ID# 273657
RECRUITING

Yokohama, Kanagawa, 232-0024, Japan

Conditions

Explore the condition pages connected to this study.

COLORECTAL CANCER